Atreca Inc (BCEL)
0.0891
0.00 (0.00%)
USD |
OTCM |
May 01, 12:52
Atreca 1 Year Total Returns (Daily): -91.10% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | -91.10% |
April 29, 2024 | -91.20% |
April 26, 2024 | -90.91% |
April 25, 2024 | -90.55% |
April 24, 2024 | -90.66% |
April 23, 2024 | -91.19% |
April 22, 2024 | -90.64% |
April 19, 2024 | -92.22% |
April 18, 2024 | -91.70% |
April 17, 2024 | -91.80% |
April 16, 2024 | -91.83% |
April 15, 2024 | -91.29% |
April 12, 2024 | -91.23% |
April 11, 2024 | -91.15% |
April 10, 2024 | -91.86% |
April 09, 2024 | -92.57% |
April 08, 2024 | -91.87% |
April 05, 2024 | -93.03% |
April 04, 2024 | -93.07% |
April 03, 2024 | -93.00% |
April 02, 2024 | -93.33% |
April 01, 2024 | -92.98% |
March 28, 2024 | -93.77% |
March 27, 2024 | -93.64% |
March 26, 2024 | -93.50% |
Date | Value |
---|---|
March 25, 2024 | -94.23% |
March 22, 2024 | -93.90% |
March 21, 2024 | -93.75% |
March 20, 2024 | -95.08% |
March 19, 2024 | -94.37% |
March 18, 2024 | -88.28% |
March 15, 2024 | -87.22% |
March 14, 2024 | -85.79% |
March 13, 2024 | -86.62% |
March 12, 2024 | -88.03% |
March 11, 2024 | -84.96% |
March 08, 2024 | -85.83% |
March 07, 2024 | -84.20% |
March 06, 2024 | -84.32% |
March 05, 2024 | -83.20% |
March 04, 2024 | -82.80% |
March 01, 2024 | -78.32% |
February 29, 2024 | -81.82% |
February 28, 2024 | -81.33% |
February 27, 2024 | -80.99% |
February 26, 2024 | -79.07% |
February 23, 2024 | -80.64% |
February 22, 2024 | -80.25% |
February 21, 2024 | -81.12% |
February 20, 2024 | -80.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.08%
Minimum
Mar 20 2024
58.09%
Maximum
Nov 27 2020
-51.42%
Average
-62.60%
Median
Jun 24 2021
1 Year Total Returns (Daily) Benchmarks
Catalent Inc | 11.43% |
NovaBay Pharmaceuticals Inc | -92.97% |
Palatin Technologies Inc | -18.42% |
iBio Inc | -92.08% |
Theriva Biologics Inc | -36.11% |